Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 11-2025 | 08-2025 | 05-2025 | 02-2025 | 11-2024 | |
| Sales | 13,577 | 7,894 | 44,056 | 18,453 | 13,284 |
| Gross Profit | 13,577 | 7,894 | 44,056 | 18,453 | 13,284 |
| Operating Expenses | 96,672 | 99,279 | 92,378 | 81,317 | 77,941 |
| Operating Income | -83,095 | -91,385 | -48,322 | -62,864 | -64,657 |
| Other Income | 4,874 | 4,964 | 5,618 | 6,513 | 6,116 |
| Pre-tax Income | -78,221 | -86,421 | -42,704 | -56,351 | -58,541 |
| Income Tax | N/A | 0 | 760 | N/A | 8 |
| Net Income Continuous | -78,221 | -86,421 | -43,464 | -56,351 | -58,549 |
| Net Income | $-78,221 | $-86,421 | $-43,464 | $-56,351 | $-58,549 |
| EPS Basic Total Ops | -0.83 | -1.03 | -0.52 | -0.67 | -0.74 |
| EPS Basic Continuous Ops | -0.83 | -1.03 | -0.52 | -0.67 | -0.74 |
| EPS Diluted Total Ops | -0.83 | -1.03 | -0.52 | -0.67 | -0.74 |
| EPS Diluted Continuous Ops | -0.83 | -1.03 | -0.52 | -0.67 | -0.74 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.03 | -0.52 | -0.67 | -0.75 |
| EBITDA(a) | $-88,786 | $-86,385 | $-43,225 | $-58,736 | $-71,642 |